Near-Infrared Molecular Imaging of Glioblastoma by Miltuximab(®)-IRDye800CW as a Potential Tool for Fluorescence-Guided Surgery

Glioblastoma (GBM) is one of the most aggressive tumors and its 5-year survival is approximately 5%. Fluorescence-guided surgery (FGS) improves the extent of resection and leads to better prognosis. Molecular near-infrared (NIR) imaging appears to outperform conventional FGS, however, novel molecula...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Polikarpov, Dmitry M., Campbell, Douglas H., McRobb, Lucinda S., Wu, Jiehua, Lund, Maria E., Lu, Yanling, Deyev, Sergey M., Davidson, Andrew S., Walsh, Bradley J., Zvyagin, Andrei V., Gillatt, David A.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7226459/
https://ncbi.nlm.nih.gov/pubmed/32316186
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12040984
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados